Technical Analysis for ADXS - Advaxis, Inc.

Grade Last Price % Change Price Change
grade F 0.37 23.33% 0.07
ADXS closed up 23.33 percent on Wednesday, January 16, 2019, on 1.85 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical ADXS trend table...

Date Alert Name Type % Chg
Jan 16 50 DMA Resistance Bearish 0.00%
Jan 16 Earnings Movers Other 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 15 Calm After Storm Range Contraction 23.33%
Jan 15 Narrow Range Bar Range Contraction 23.33%
Jan 15 NR7 Range Contraction 23.33%
Jan 15 Wide Bands Range Expansion 23.33%
Jan 14 Calm After Storm Range Contraction 27.59%
Jan 14 Doji - Bullish? Reversal 27.59%
Jan 14 Wide Bands Range Expansion 27.59%

Older signals for ADXS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Advaxis, Inc., a clinical development stage biotechnology company, engages in the development of immunotherapies for cancer and infectious diseases. The company's platform technology generates an immune response by serving as its own adjuvant, directing antigen presentation, increasing tumor infiltrating killer T-cells, and decreasing Tregs/MDSCs in the tumor. It has approximately 15 distinct constructs in various stages of development, directly developed by the company and through strategic collaborations. The company's products in clinical development stage include ADXS-HPV that is being evaluated in clinical trials for cervical cancer, CIN 2/3, head and neck cancer, and anal cancer. Its products in clinical development stage also comprise ADXS-PSA for prostate cancer; and ADXS-cHER2 for overexpressing cancers, such as breast, gastric, and other cancers in humans, as well as for osteosarcoma in canines. The company was founded in 2002 and is based in Princeton, New Jersey.
Is ADXS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.3
52 Week Low 0.18
Average Volume 879,361
200-Day Moving Average 1.1327
50-Day Moving Average 0.376
20-Day Moving Average 0.2673
10-Day Moving Average 0.3271
Average True Range 0.0548
ADX 45.31
+DI 33.3029
-DI 18.3655
Chandelier Exit (Long, 3 ATRs ) 0.2756
Chandelier Exit (Short, 3 ATRs ) 0.3444
Upper Bollinger Band 0.4093
Lower Bollinger Band 0.1253
Percent B (%b) 0.86
BandWidth 106.247662
MACD Line -0.008
MACD Signal Line -0.0256
MACD Histogram 0.0176
Fundamentals Value
Market Cap 15.19 Million
Num Shares 41.1 Million
EPS -2.29
Price-to-Earnings (P/E) Ratio -0.16
Price-to-Sales 9.06
Price-to-Book 1.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.52
Resistance 3 (R3) 0.51 0.46 0.50
Resistance 2 (R2) 0.46 0.42 0.46 0.49
Resistance 1 (R1) 0.41 0.39 0.44 0.42 0.48
Pivot Point 0.36 0.36 0.37 0.36 0.36
Support 1 (S1) 0.31 0.32 0.34 0.32 0.26
Support 2 (S2) 0.26 0.29 0.26 0.25
Support 3 (S3) 0.21 0.26 0.25
Support 4 (S4) 0.22